Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World Study

Background: No consensus exists on the possibility to stop disease modifying therapies (DMTs) in Secondary Progressive Multiple Sclerosis (SPMS). Methods: The primary outcome was the time to reach 24-weeks confirmed Expanded Disability Status Scale (EDSS) 7.0. We enrolled all patients with a confirm...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanghì, Aurora, D’Amico, Emanuele, Patti, Francesco, Avolio, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140489/
https://www.ncbi.nlm.nih.gov/pubmed/35627605
http://dx.doi.org/10.3390/ijerph19106069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140489/
https://www.ncbi.nlm.nih.gov/pubmed/35627605
http://dx.doi.org/10.3390/ijerph19106069

Ejemplares similares